Overview

Dexmedetomidine for Pain Reduction in CABG

Status:
Not yet recruiting
Trial end date:
2024-05-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether adjuvant intravenous dexmedetomidine infusion starting after induction of general anesthesia can provide superior pain management (decrease pain scores) and decrease opioid administration, without increasing nausea/vomiting, compared to patients receiving only opioid and acetaminophen for the patients which going through coronary artery bypass grafting (CABG)?
Phase:
N/A
Details
Lead Sponsor:
Wayne State University
Treatments:
Dexmedetomidine
Pharmaceutical Solutions